mechanism of action for glp 1 receptor agonists Frontiers GLP1 - Mechanism of Action

*Most people will not pay the list price for medication

GLP-1 agonists like liraglutide (Victoza), lixisenatide (Adlyxin), dulaglutide (Trulicity), and semaglutide (Ozempic, Rybelsus) are commonly prescribed and continue to demonstrate benefits beyond just controlling blood sugar, including improvements in heart and metabolic health for some drugs

These findings have prompted the development of perioperative guidelines and heightened awareness among anesthesiologists and gastroenterologists

Dulaglutide also has shown kidney benefits (slower progression of albuminuria) in that trial

To date, these GLP-1 drugs have been approved to treat three adult populations: individuals with type 2 diabetes, individuals with a body mass index (BMI) of 30 or greater (obesity), and individuals with a BMI between 27 and 30 (overweight) with at least one weight-related health condition, such as cardiovascular disease, high blood pressure, high cholesterol, prior stroke, prior heart attack, and chest pain (angina)

Understanding GLP-1 GLP-1 is a hormone secreted by the intestine in response to food intake